Mindham R H
Br J Clin Pharmacol. 1976 Jun;3(3 Suppl 2):395-400. doi: 10.1111/j.1365-2125.1976.tb03732.x.
I have tried to bring out some of the important methodological problems found in examining the effectiveness of drugs used in the control of druginduced parkinsonism by referring mainly to studies in which I have taken part. I hope I have shown that the whole topic is far less well understood than is often assumed. The main points may be summarized as follows: there is doubt as to whether many of the drugs used in controlling drug-induced parkinsonism are really effective; the results of many studies are conflicting; many studies contain serious flaws in design; methods for assessing extrapyramidal signs are not well developed; we are ignorant of the way in which drug-induced extrapyramidal signs change spontaneously. There is a clear need for further research in this area to improve techniques of assessment, to provide basic information on drug-induced syndromes, and to rigorously examine the efficacy of the drugs used in controlling them.
我试图通过主要参考我参与的研究,来阐述在检验用于控制药物性帕金森综合征的药物疗效时发现的一些重要方法学问题。我希望我已经表明,整个主题远没有人们通常认为的那么容易理解。要点总结如下:对于许多用于控制药物性帕金森综合征的药物是否真的有效存在疑问;许多研究结果相互矛盾;许多研究在设计上存在严重缺陷;评估锥体外系症状的方法尚未充分发展;我们对药物性锥体外系症状自发变化的方式一无所知。显然有必要在这一领域进行进一步研究,以改进评估技术,提供有关药物性综合征的基础信息,并严格检验用于控制这些症状的药物的疗效。